⌘K
Loading ticker…
As of 2026-08-25, Thermo Fisher Scientific, Inc. (TMO) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.6%, relative volume 0.82×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
TMO is held by 4 ETFs as of Jun 2026. Top owner: LCAP at 1.43% weight, $26M notional. Top 3 carry $27M.
Held by 310 ETFs · $24.9B across latest filings · largest weight 4.59% (TMED).
Top 4 by value, from SEC N-PORT-P filings dated Jun 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMO Jan avg: 4.97% median: 2.56% win: 75% σ: 6.79% n: 4 2022-04-12 → 2026-07-31 | TMO Feb avg: -5.17% median: -7.47% win: 25% σ: 7.81% n: 4 2022-04-12 → 2026-07-31 | TMO Mar avg: -0.82% median: -1.87% win: 50% σ: 6.03% n: 4 2022-04-12 → 2026-07-31 | TMO Apr avg: -5.56% median: -3.72% win: 0% σ: 4.79% n: 5 2022-04-12 → 2026-07-31 | TMO May avg: -1.82% median: -0.13% win: 40% σ: 5.14% n: 5 2022-04-12 → 2026-07-31 | TMO Jun avg: -0.37% median: 0.66% win: 60% σ: 2.96% n: 5 2022-04-12 → 2026-07-31 | TMO Jul avg: 11.22% median: 10.91% win: 100% σ: 4.06% n: 5 2022-04-12 → 2026-07-31 | TMO Aug avg: -0.42% median: 0.91% win: 75% σ: 6.03% n: 4 2022-04-12 → 2026-07-31 (current) | TMO Sep avg: -4.28% median: -4.28% win: 25% σ: 4.54% n: 4 2022-04-12 → 2026-07-31 | TMO Oct avg: -1.37% median: -5.17% win: 50% σ: 13.74% n: 4 2022-04-12 → 2026-07-31 | TMO Nov avg: 5.38% median: 6.57% win: 75% σ: 6.40% n: 4 2022-04-12 → 2026-07-31 | TMO Dec avg: 0.42% median: -1.74% win: 25% σ: 4.43% n: 4 2022-04-12 → 2026-07-31 |